{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:29:57Z","timestamp":1773296997874,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.beha.2007.03.002","type":"journal-article","created":{"date-parts":[[2007,8,18]],"date-time":"2007-08-18T11:16:56Z","timestamp":1187435816000},"page":"529-543","source":"Crossref","is-referenced-by-count":8,"title":["The role of stem-cell transplantation in chronic lympocytic leukemia risk-adapted therapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Eva","family":"Gin\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emili","family":"Montserrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2007.03.002_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2007.03.002_bib3","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1200\/JCO.2003.02.134","article-title":"Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia","volume":"21","author":"Vasconcelos","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2007.03.002_bib4","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1182\/blood.V95.9.2786.009k30_2786_2792","article-title":"Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features","volume":"95","author":"Mauro","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.leu.2400679","article-title":"Chronic lymphocytic leukemia: a changing natural history?","volume":"11","author":"Rozman","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2007.03.002_bib6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1182\/blood-2005-04-1677","article-title":"Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia","volume":"107","author":"Binet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib8","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/jnci\/91.10.861","article-title":"Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group","volume":"91","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.beha.2007.03.002_bib10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199805213382104","article-title":"Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia","volume":"338","author":"Dighiero","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beha.2007.03.002_bib11","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJM200012143432402","article-title":"Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia","volume":"343","author":"Rai","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beha.2007.03.002_bib12","first-page":"716","article-title":"Early Results from LRF CLL4: A UK Multicenter Randomized Trial","volume":"106","author":"Catovsky","year":"2005","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.beha.2007.03.002_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood-2005-06-2395","article-title":"Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia","volume":"107","author":"Eichhorst","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib14","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.leu.2403940","article-title":"Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706","volume":"19","author":"Hussein","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2007.03.002_bib15","first-page":"2977","article-title":"A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia","volume":"106","author":"Shustik","year":"2005","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.beha.2007.03.002_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1365-2141.2002.03959.x","article-title":"Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia","volume":"119","author":"Bosch","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2007.03.002_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2004-03-0796","article-title":"Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib18","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1200\/JCO.2005.12.051","article-title":"Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia","volume":"23","author":"Keating","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2007.03.002_bib19","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1200\/JCO.2005.12.516","article-title":"Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia","volume":"23","author":"Wierda","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2007.03.002_bib20","unstructured":"Dreger P, Corradini P & Kimby E. Indications for allogenic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia, in press."},{"key":"10.1016\/j.beha.2007.03.002_bib21","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/sj.leu.2403984","article-title":"The evolving role of alemtuzumab in management of patients with CLL","volume":"19","author":"Faderl","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2007.03.002_bib22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.leu.2402530","article-title":"Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia","volume":"16","author":"Dreger","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2007.03.002_bib23","first-page":"482a","article-title":"Prognostic factors for survival after autologous stem cell transplantation for chronic lymphocytic leukemia (CLL): the EBMT experience [abstract]","volume":"96","author":"Dreger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib24","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1182\/blood-2002-06-1744","article-title":"Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia","volume":"101","author":"Ritgen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2003-05-1449","article-title":"Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia","volume":"103","author":"Tournilhac","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.leu.2403190","article-title":"Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H","volume":"18","author":"Montillo","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2007.03.002_bib27","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2006-04-007898","article-title":"Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia","volume":"108","author":"Zenz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib28","article-title":"Efficacy and prognostic implications of early autologous stem cell transplantation for poor risk CLL [abstract]","volume":"96","author":"Dreger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib29","article-title":"Stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL): outcome and prognostic factors after autologous and allogenic transplants [abstract]","volume":"98","author":"Esteve","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib30","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood-2005-05-1778","article-title":"Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia","volume":"106","author":"Gribben","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1705375","article-title":"Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience","volume":"37","author":"Jantunen","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2007.03.002_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2004-01-0298","article-title":"Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses","volume":"105","author":"Milligan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib33","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1182\/blood-2003-05-1549","article-title":"The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status","volume":"103","author":"Dreger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib34","article-title":"Comparative study between autologous or allogenic transplantations and conventional chemotherapy in chronic lymphocytic leukemia (CLL): A European Blood and Marrow Transplantation (EBMT) and French CLL Cooperative Group Study [abstract]","author":"Michallet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2007.03.002_bib35","first-page":"1122","article-title":"Treatment-Related MDS\/AML after Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL): An EBMT Survey","volume":"106","author":"Dreger","year":"2005","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.beha.2007.03.002_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2006.05982.x","article-title":"High incidence of myelodysplasia and secondary leukaemia in the UK Medical Research Council Pilot of autografting in chronic lymphocytic leukaemia","volume":"133","author":"Milligan","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2007.03.002_bib37","first-page":"1546","article-title":"Treatment-related myelodysplasia following fludarabine combination chemotherapy","volume":"91","author":"Tam","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2007.03.002_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2141.2006.06158.x","article-title":"High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders","volume":"134","author":"Bowcock","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beha.2007.03.002_bib39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2005-02-0819","article-title":"How I treat refractory CLL","volume":"107","author":"Montserrat","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bmt.1703548","article-title":"Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia","volume":"29","author":"Doney","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 2","key":"10.1016\/j.beha.2007.03.002_bib41","first-page":"41","article-title":"Prolonged response after allogeneic stem-cell transplantation (alloSCT) for high-risk chronic lymphoblastic leukemia (CLL): long term outcome of a series from a single institution [abstract]","volume":"90","author":"Esteve","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2007.03.002_bib42","article-title":"Haematopoietic stem cell transplantation for chronic lymphocytic leukemia [abstract]","volume":"96","author":"Horowitz","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/146532402320219736","article-title":"Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation","volume":"4","author":"Khouri","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1016\/j.beha.2007.03.002_bib44","article-title":"Conventional HLA-Identical Sibling Bone Marrow Transplantation Is Able To Cure Chronic Lymphocytic Leukemia. A Study from the EBMT and IBMT Registries [abstract]","volume":"102","author":"Michallet","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bmt.1702237","article-title":"Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia","volume":"25","author":"Pavletic","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2007.03.002_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bmt.1705130","article-title":"Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease","volume":"36","author":"Toze","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.beha.2007.03.002_bib47","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1200\/JCO.2005.04.531","article-title":"Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia","volume":"23","author":"Moreno","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2007.03.002_bib48","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1158\/1078-0432.CCR-05-0941","article-title":"Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-)","volume":"11","author":"Caballero","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.beha.2007.03.002_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exphem.2003.09.021","article-title":"Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival","volume":"32","author":"Khouri","year":"2004","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.beha.2007.03.002_bib50","first-page":"561","article-title":"Transplant Outcome of Unrelated Hematopoietic Stem Cell Transplantation (HSCT) after Myelo-Ablative or Reduced Intensity Conditioning (RIC) for Chronic Lymphocytic Leukemia(CLL). A Study of EBMT Registry","volume":"106","author":"Michallet","year":"2005","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.beha.2007.03.002_bib51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.seminhematol.2004.05.001","article-title":"Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients","volume":"41","author":"Rawstron","year":"2004","journal-title":"Seminars in Hematology"},{"key":"10.1016\/j.beha.2007.03.002_bib52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.leu.2402905","article-title":"Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning","volume":"17","author":"Dreger","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2007.03.002_bib53","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2003.12.011","article-title":"Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group","volume":"21","author":"Schetelig","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2007.03.002_bib54","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2005.04.569","article-title":"Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia","volume":"23","author":"Sorror","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2007.03.002_bib55","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.leu.2403745","article-title":"Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis","volume":"19","author":"Dreger","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2007.03.002_bib56","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1200\/JCO.2005.03.962","article-title":"Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research","volume":"23","author":"Pavletic","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.beha.2007.03.002_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2141.2000.01900.x","volume":"108","author":"Michallet","year":"2000","journal-title":"Journal of Haematology"},{"key":"10.1016\/j.beha.2007.03.002_bib58","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1182\/blood-2005-08-3372","article-title":"Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study","volume":"107","author":"Delgado","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2007.03.002_bib59","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bbmt.2006.06.004","article-title":"Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia","volume":"12","author":"Brown","year":"2006","journal-title":"Biology of Blood and Marrow Transplantation"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692607000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692607000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T23:57:59Z","timestamp":1587859079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692607000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1521692607000394"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2007.03.002","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}